搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Cytophaga hutchinsonii 30S ribosomal protein S9 (rpsI) CSB-YP609076CAAO
CSB-EP609076CAAO
CSB-BP609076CAAO
CSB-MP609076CAAO
CSB-EP609076CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Malate dehydrogenase (mdh) CSB-YP609077CAAO
CSB-EP609077CAAO
CSB-BP609077CAAO
CSB-MP609077CAAO
CSB-EP609077CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii ATP-dependent dethiobiotin synthetase BioD (bioD) CSB-YP609078CAAO
CSB-EP609078CAAO
CSB-BP609078CAAO
CSB-MP609078CAAO
CSB-EP609078CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP609079CAAO
CSB-EP609079CAAO
CSB-BP609079CAAO
CSB-MP609079CAAO
CSB-EP609079CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 6-phosphofructokinase (pfkA) CSB-YP609080CAAO
CSB-EP609080CAAO
CSB-BP609080CAAO
CSB-MP609080CAAO
CSB-EP609080CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii UPF0176 protein CHU_2691 (CHU_2691) CSB-YP609081CAAO
CSB-EP609081CAAO
CSB-BP609081CAAO
CSB-MP609081CAAO
CSB-EP609081CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Orotate phosphoribosyltransferase (pyrE) CSB-YP609082CAAO
CSB-EP609082CAAO
CSB-BP609082CAAO
CSB-MP609082CAAO
CSB-EP609082CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Membrane protein insertase YidC (yidC), partial CSB-YP609083CAAO1
CSB-EP609083CAAO1
CSB-BP609083CAAO1
CSB-MP609083CAAO1
CSB-EP609083CAAO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii CinA-like protein (CHU_2526) CSB-YP609084CAAO
CSB-EP609084CAAO
CSB-BP609084CAAO
CSB-MP609084CAAO
CSB-EP609084CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Putative membrane protein insertion efficiency factor (CHU_2420) CSB-YP609085CAAO
CSB-EP609085CAAO
CSB-BP609085CAAO
CSB-MP609085CAAO
CSB-EP609085CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Protoheme IX farnesyltransferase (ctaB), partial CSB-YP609086CAAO
CSB-EP609086CAAO
CSB-BP609086CAAO
CSB-MP609086CAAO
CSB-EP609086CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Deoxycytidine triphosphate deaminase (dcd) CSB-YP609087CAAO
CSB-EP609087CAAO
CSB-BP609087CAAO
CSB-MP609087CAAO
CSB-EP609087CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Ribonuclease Z (rnz) CSB-YP609088CAAO
CSB-EP609088CAAO
CSB-BP609088CAAO
CSB-MP609088CAAO
CSB-EP609088CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii ATP phosphoribosyltransferase (hisG) CSB-YP609089CAAO
CSB-EP609089CAAO
CSB-BP609089CAAO
CSB-MP609089CAAO
CSB-EP609089CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii 30S ribosomal protein S15 (rpsO) CSB-YP609090CAAO
CSB-EP609090CAAO
CSB-BP609090CAAO
CSB-MP609090CAAO
CSB-EP609090CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Elongation factor 4 (lepA), partial CSB-YP609091CAAO
CSB-EP609091CAAO
CSB-BP609091CAAO
CSB-MP609091CAAO
CSB-EP609091CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Threonine--tRNA ligase (thrS), partial CSB-YP609092CAAO
CSB-EP609092CAAO
CSB-BP609092CAAO
CSB-MP609092CAAO
CSB-EP609092CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Phosphate acyltransferase (plsX) CSB-YP609093CAAO
CSB-EP609093CAAO
CSB-BP609093CAAO
CSB-MP609093CAAO
CSB-EP609093CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Tyrosine--tRNA ligase (tyrS) CSB-YP609094CAAO
CSB-EP609094CAAO
CSB-BP609094CAAO
CSB-MP609094CAAO
CSB-EP609094CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytophaga hutchinsonii Acyl carrier protein (acpP) CSB-YP609095CAAO
CSB-EP609095CAAO
CSB-BP609095CAAO
CSB-MP609095CAAO
CSB-EP609095CAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>